New Neuroendocrine Tumor Trial at Sylvester Cancer Center

For patients facing high-grade neuroendocrine tumors (NETs), the medical landscape has long been defined by a stark reality: limited options and a devastatingly aggressive disease progression. However, a new clinical trial at the Sylvester Comprehensive Cancer Center is attempting to rewrite this narrative by shifting the strategy from systemic toxicity to precision immunotherapy. Key Takeaways: … Read more

Jumping Genes & Cancer: Genome Instability Link Found

The Genome’s Hidden Instability: How ‘Jumping Genes’ Could Rewrite Cancer Treatment Nearly half of the human genome is comprised of transposable elements – often called “jumping genes” – remnants of ancient viruses and genetic parasites. For decades, these sequences were largely dismissed as ‘junk DNA.’ Now, groundbreaking research reveals they aren’t inert at all. In … Read more